严重脓毒症发热与不发热患者的单核细胞功能及临床结局
本研究为单中心前瞻性队列研究,纳入92例危重脓毒症患者,按脓毒症诊断后24小时内体温分为发热组(≥38.0°C)与不发热组(<38.0°C)。在诊断后第1-2天、第3-4天、第6-8天检测HLA-DR表达和LPS诱导的TNF-α产生。结果显示各时间点两组间HLA-DR表达和TNF-α产生无显著差异,但发热组HLA-DR表达从第1-2天至第6-8天显著升高(中位差值8118抗体/细胞,P=0.002),不发热组无显著变化(中位差值403抗体/细胞,P=0.25)。不发热组28天死亡率更高(37.5% vs 18.2%),继发感染获得率更高(35.4% vs 15.9%)。结论提示不发热与HLA-DR表达受抑及更差临床结局相关。
要点
- 不发热脓毒症患者28天死亡率37.5%,显著高于发热患者的18.2%。
- 不发热组继发感染获得率35.4%,高于发热组的15.9%。
- 发热组HLA-DR表达从第1-2天至第6-8天显著升高(中位差值8118抗体/细胞,P=0.002)。
- 不发热组HLA-DR表达无显著变化(中位差值403抗体/细胞,P=0.25)。
- 各单个时间点两组HLA-DR表达和LPS诱导TNF-α产生无显著差异。
适用人群与场景
- 单中心前瞻性队列研究纳入的92例危重脓毒症患者。
- 按脓毒症诊断后24小时内体温分为发热组(≥38.0°C)和不发热组(<38.0°C)。
诊断标准与关键阈值
- 发热定义为脓毒症诊断后24小时内体温≥38.0°C;不发热定义为体温<38.0°C。
研究设计与关键结果
- 研究类型为单中心前瞻性队列研究,样本量92例危重脓毒症患者。
- 44例(47.8%)在脓毒症诊断后24小时内出现发热。
- 各单个时间点发热组与不发热组HLA-DR表达和LPS诱导TNF-α产生无显著差异。
- 发热组HLA-DR表达从第1-2天至第6-8天显著升高,中位差值8118抗体/细胞(IQR 1,662-9,878),P=0.002。
- 不发热组HLA-DR表达从第1-2天至第6-8天无显著变化,中位差值403抗体/细胞(IQR -3,382-3,507),P=0.25。
- 不发热组28天死亡率37.5%,发热组18.2%。
- 不发热组继发感染获得率35.4%,发热组15.9%。
证据类型、等级与局限
- 证据类型:单中心前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为不发热与HLA-DR表达随时间受抑相关,提示脓毒症中单核细胞功能障碍,并与更差临床结局相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Absence of fever is associated with higher mortality in septic patients, but the reason for this is unknown. Immune dysfunction may be a potential link between failure to mount a fever and poor outcomes. The purpose of this study was to evaluate monocyte function and clinical surrogates of immunity (i.e., mortality and acquisition of secondary infections) in febrile and afebrile septic patients.
METHODS: Single-center, prospective cohort study of 92 critically ill septic patients. Patients were categorized into febrile (≥38.0°C) and afebrile (<38.0°C) groups based on temperature measurements within 24 hours of sepsis diagnosis. HLA-DR expression and LPS-induced TNF-α production were quantified on days 1-2, days 3-4, and days 6-8 after sepsis diagnosis. A repeated measures mixed models analysis was used to compare these markers between the two groups.
RESULTS: Forty-four patients (47.8%) developed a fever within 24 h of sepsis diagnosis. There were no significant differences in HLA-DR expression or LPS-induced TNF-α production between febrile and afebrile patients at any individual time point. However, HLA-DR expression significantly increased between days 1-2 and days 6-8 (median difference 8118 [IQR 1,662, 9,878] antibodies/cell, P = 0.002) in febrile patients, but not in afebrile patients (median difference 403 [-3,382, 3,507] antibodies/cell, P = 0.25). Afebrile patients demonstrated higher 28-day mortality (37.5% vs 18.2%) and increased acquisition of secondary infections (35.4% vs. 15.9%).
CONCLUSIONS: Absence of fever is associated with suppressed HLA-DR expression over time, a finding suggestive of monocyte dysfunction in sepsis, as well as worse clinical outcomes.
参考来源
- Drewry AM, Ablordeppey EA, Murray ET, et al. Monocyte Function and Clinical Outcomes in Febrile and Afebrile Patients With Severe Sepsis. Shock. 2018. PMID: 29240644. doi:10.1097/SHK.0000000000001083
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。